Finerenone in chronic kidney disease
Journal of Kidney Care · 02.07.2026 · 11 (4) · 206-206
DOI: 10.12968/jokc.2026.0047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Kidney Care, erschienen am 02.07.2026. Verfasst von Peter Ellis. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
New trial evidence suggests that finerenone may slow kidney disease progression and reduce cardiovascular risk in people with non-diabetic chronic kidney disease, including those with glomerular disease. These findings raise the possibility of a broader future role for finerenone in nephrology practice.
Zitieren
APA
Ellis, P. (2026). Finerenone in chronic kidney disease. Journal of Kidney Care, 11(4), 206-206. https://doi.org/10.12968/jokc.2026.0047
Vancouver
Ellis P. Finerenone in chronic kidney disease. Journal of Kidney Care. 2026;11(4):206-206. doi:10.12968/jokc.2026.0047
BibTeX
@article{Ellis2026,
author = {Ellis, Peter},
title = {Finerenone in chronic kidney disease},
journal = {Journal of Kidney Care},
year = {2026},
volume = {11},
number = {4},
pages = {206--206},
doi = {10.12968/jokc.2026.0047}
}
EUVIMED